NDC 11673-295 - Maximum Strength Daytime Cold and Flu and Nighttime Severe Cold and Flu
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-295
- Package NDCs from labels
- 11673-295-03
- Manufacturer
- TARGET CORPORATION | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2024-08-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Target Daytime Cold & Flu and Nighttime Severe Cold & Flu Liquid | TARGET CORPORATION | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | 2024-08-22 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-295-03 | Maximum Strength Daytime Cold and Flu and Nighttime Severe Cold and Flu | 180 mL in 1 BOTTLE | SOLUTION | 180 mL | 650 mg in 20mL | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11673-295 | MAXIMUM STRENGTH DAYTIME COLD AND FLU AND NIGHTTIME SEVERE COLD AND FLU (ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, AND ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE,TRIPROLIDINE HYDROCHLORIDE) KIT [TARGET CORPORATION] | 3 | Unmatched | 20240823_0fc523ce-55a7-6384-e063-6394a90aad3f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Crcle Guaifenesin Extended-Release Tablets, 600 mg | GUAIFENESIN EXTENDED-RELEASE | Innovus Pharmaceuticals, Inc. | bba4b91a-bea9-41be-9588-5fb1483c7d10 | 2023-04-08 | Warnings | 495W7451VQ |
| Sterile Water | WATER | Civica, Inc. | 3f49eedf-5bf5-4a95-b704-c956d860ca04 | 2023-04-07 | Warnings, Adverse reactions | 059QF0KO0R |
| DG Health Mucus ER | GUAIFENESIN | Dolgencorp, LLC | bf99fa83-c3be-4052-b5b6-ad91997cb034 | 2023-04-06 | Warnings | 495W7451VQ |
| Mucus Relief DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | Strategic Sourcing Services LLC | 5eb5f84f-4cb8-4552-b73d-c2b27657fa15 | 2023-04-06 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Treprostinil | TREPROSTINIL | Sandoz Inc | 473297ca-a872-4052-a053-87dc8f0d3c13 | 2023-04-06 | Warnings, Adverse reactions | 059QF0KO0R |
| DG Health migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Dolgencorp, LLC | d0e82cac-dfbb-49cb-99c8-560b02fb1a8c | 2023-04-05 | Warnings | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Proficient Rx LP | 82b24978-8b15-43a9-b5b0-3313ed2a73c2 | 2023-04-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Bausch & Lomb Americas Inc. | dcd09e27-93ec-463f-8062-a7dad96c4d0f | 2023-03-31 | Warnings, Adverse reactions | 04JA59TNSJ |
| Virility Liquescence | AVENA SATIVA, DAMIANA, BERBERIS VULGARIS, EPIMEDIUM GRANDIFLORUM, GLYCERINUM, SABAL SERRULATA, IODIUM, LECITHIN, FERRUM MURIATICUM, NATRUM MURIATICUM, AGNUS CASTUS, BUFO RANA, CINCHONA OFFICINALIS, HUMAN GROWTH HORMONE (HGH), ORCHITINUM (BOVINE), PHOSPHORICUM ACIDUM, PHOSPHORUS, SELENIUM METALLICUM, ZINCUM VALERIANICUM, OOPHORINUM (SUIS), SEPIA | Nutritional Specialties, Inc. | 81cc3e2b-f95e-4ba4-a15f-c07b4def0e2f | 2023-03-29 | Warnings | PDC6A3C0OX |
| Vitamin C Liquescence | CITRUS VULGARIS, CITRUS LIMONUM, MALPIGHIA SPP, PETROSELINUM SATIVUM, ROSA CANINA, AGARICUS MUSCARIUS, ASCORBICUM ACIDUM, CAPSICUM ANNUUM, MEDULLA OSSIS SUIS, SOLANUM TUBEROSUM | Nutritional Specialties, Inc. | 1864d967-071f-4c2f-a71a-f2b7da47a3d5 | 2023-03-28 | Warnings | PQ6CK8PD0R |
| PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | Armas Pharmaceuticals Inc. | 16c02d53-fd3f-4fd7-abbe-f1358ea0891f | 2023-03-28 | Warnings, Adverse reactions | 04JA59TNSJ |
| GUAIFENESIN | GUAIFENESIN | Safrel Pharmaceuticals, LLC. | e2a3d6cb-5251-b88e-e053-2a95a90a9e30 | 2023-03-28 | Warnings | 495W7451VQ |
| Emetrol Chewables Mixed Berry | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 4965fab0-828d-4f1d-8d43-a636e0a8c1ea | 2023-03-23 | Warnings | B22547B95K |
| Emetrol Chewables Orange | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | e9072f9d-d74c-4e43-bcfe-ee005577df35 | 2023-03-23 | Warnings | B22547B95K |
| Butalbital, Acetaminophen and Caffeine | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Golden State Medical Supply, Inc. | ee131bce-863b-b5a1-e053-2a95a90afc79 | 2023-03-16 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Mucinex DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Navajo Manufacturing Company Inc. | 4226f394-f85e-45b1-8d5f-7cffb7dd492f | 2023-03-16 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Advil Allergy and Congestion Relief | CHLORPHENIRAMINE MALEATE, IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE | Navajo Manufacturing Company Inc. | d40bf078-ee6f-4c64-9c74-e4e770c150bf | 2023-03-15 | Warnings | 04JA59TNSJ |
| Advil Sinus Congestion and Pain Relief | IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE | Navajo Manufacturing Company Inc. | 531abadc-37fd-4953-95bc-a211a2ba6914 | 2023-03-15 | Warnings | 04JA59TNSJ |
| GUAIFENESIN - ODAAT 1200 MG | GUAIFENESIN | LODAAT LLC | f61d3ae0-11eb-2a82-e053-2995a90a95da | 2023-03-04 | Warnings | 495W7451VQ |
| Insulin Diluting Medium for NovoLog | WATER INJECTION | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.